Literature DB >> 17889400

Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models.

Biana Godin1, Elka Touitou.   

Abstract

The assessment of percutaneous permeation of molecules is one of the main steps in the initial design and later in the evaluation of dermal or transdermal drug delivery systems. The literature reports numerous ex vivo, in vitro and in vivo models used to determine drug skin permeation profiles and kinetic parameters, some studies focusing on the correlation of the data obtained using these models with the dermal/transdermal absorption in humans. This paper reviews work from in vitro permeation studies to clinical performance, presenting various experimental models used in dermal/transdermal research, including the use of excised human or animal skin, cultured skin equivalents and animals. Studies focusing on transdermal absorption of a series of drug molecules and various delivery systems as well as mathematical models for skin absorption are reviewed.

Entities:  

Mesh:

Year:  2007        PMID: 17889400     DOI: 10.1016/j.addr.2007.07.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  105 in total

1.  In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography.

Authors:  Siôn A Coulman; James C Birchall; Aneesh Alex; Marc Pearton; Bernd Hofer; Conor O'Mahony; Wolfgang Drexler; Boris Považay
Journal:  Pharm Res       Date:  2010-05-13       Impact factor: 4.200

2.  Gold nanoparticle penetration and reduced metabolism in human skin by toluene.

Authors:  Hagar I Labouta; David C Liu; Lynlee L Lin; Margaret K Butler; Jeffrey E Grice; Anthony P Raphael; Tobias Kraus; Labiba K El-Khordagui; H Peter Soyer; Michael S Roberts; Marc Schneider; Tarl W Prow
Journal:  Pharm Res       Date:  2011-08-11       Impact factor: 4.200

3.  Dissolving microneedles for transdermal drug delivery.

Authors:  Jeong W Lee; Jung-Hwan Park; Mark R Prausnitz
Journal:  Biomaterials       Date:  2008-02-07       Impact factor: 12.479

4.  Use of Minoxidil Sulfate versus Minoxidil Base in Androgenetic Alopecia Treatment: Friend or Foe?

Authors:  Pedro Colli Rocha Dias; Hélio Amante Miot; Ralph Michel Trüeb; Paulo Müller Ramos
Journal:  Skin Appendage Disord       Date:  2018-04-05

Review 5.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

6.  Biopolymer-based transdermal films of donepezil as an alternative delivery approach in Alzheimer's disease treatment.

Authors:  Maviye Galipoğlu; Meryem Sedef Erdal; Sevgi Güngör
Journal:  AAPS PharmSciTech       Date:  2014-10-02       Impact factor: 3.246

Review 7.  Bench approaches to study the detrimental cutaneous impact of tropospheric ozone.

Authors:  Benedetta Petracca; Barbara Rothen-Rutishauser; Giuseppe Valacchi; Marc Eeman
Journal:  J Expo Sci Environ Epidemiol       Date:  2020-10-30       Impact factor: 5.563

8.  Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet.

Authors:  Ryan F Donnelly; Kurtis Moffatt; Ahlam Zaid Alkilani; Eva M Vicente-Pérez; Johanne Barry; Maelíosa T C McCrudden; A David Woolfson
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

9.  In vitro evaluation of proniosomes as a drug carrier for flurbiprofen.

Authors:  Mahmoud Mokhtar Ahmed Ibrahim; Omaima A Sammour; Mohamed A Hammad; Nagia A Megrab
Journal:  AAPS PharmSciTech       Date:  2008-06-28       Impact factor: 3.246

10.  Utility of nanosized microemulsion for transdermal delivery of tolterodine tartrate: ex-vivo permeation and in-vivo pharmacokinetic studies.

Authors:  Ahmed H Elshafeey; Amany O Kamel; Mohsen M Fathallah
Journal:  Pharm Res       Date:  2009-08-21       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.